Tahmina Akther
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tahmina Akther has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Shamoli Saha
Assistant Professor (CC), Department of Microbiology, Bashundhara Ad-din Medical College, Dhaka, Bangladesh
2 shared publications - Afzalun Nessa
Professor, Department of Virology, Bangladesh Medical University
1 shared publication Ashrafun Nessa
Department of Gynecological oncology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
1 shared publication- Habib Shahriar
Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, Bangladesh
1 shared publication - Islam Farzana
Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, Bangladesh
1 shared publication - Munira Jahan
Department of Virology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 25 March 2025
- Published by SAGE Publications in Clinical Medicine Insights: Oncology
- Vol. 19
Patterns of Different Cervical Cytokine Expression in High-Risk Human Papillomavirus–Infected Patients With Cervical Cancer and Its Precancerous Lesions
Background: Cervical cancer is the second most common cancer in Bangladesh and is primarily caused by persistent high-risk human papillomavirus (HR-HPV) infection. Several risk factors, including immunological, genetic, environmental, and viral factors, may contribute to the development of cervical cancer. Moreover, a disruption in an otherwise delicate balance between immune response and cytokine production may lead to diseased states. Henceforth, this study aimed to determine and compare selected cytokines, including interleukin-6 (IL-6), interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interferon-gamma (INF-γ), interleukin-10 (IL-10), GM-CSF, interleukin-8 (IL-8), and MCP-1 among HR-HPV-infected patients with cervical cancer, precancer individuals, and healthy participants to test the propensity of these cytokines to serve as predictive biomarkers for the detection of cervical cancer during its early stages. Methods: A cross-sectional study was conducted on female patients visiting two referral hospitals in Bangladesh from September to November 2022. Among them, 80 women were enrolled in the study as patients with cervical cancer and precancerous lesions along with HPV DNA–negative healthy individuals. The selected cytokines in the cervical swab were estimated by flow cytometry. Result: Cervical cancer and precancer were primarily detected in patients aged above 40 years (73.3% and 46.7% of the patients in the respective groups). Other significant risk factors, including poor educational, socioeconomic status and nutritional conditions, age of first coitus, multiparity, and tobacco and betel nut consumption, were found significant for the development of cervical cancer and precancer ( P < .05). The levels of IL-6, IL-1β, IL-10, IL-8, and MCP-1 were substantially elevated in patients with cancer than in patients with precancer and healthy individuals ( P < .001). Moreover, the levels of IL-6, IL-1β, IL-10, and IL-8 were also significantly increased in patients with precancer than in healthy individuals ( P < .05). Conclusions: Thus, IL-6, IL-1β, IL-10, IL-8, and MCP-1 can be used as potential biomarkers for diagnostic and prognostic purposes in HPV-induced cervical cancer and precancer.
- 25 March 2025
- Published by SAGE Publications in Clinical Medicine Insights: Oncology
- Vol. 19
Open AccessPatterns of Different Cervical Cytokine Expression in High-Risk Human Papillomavirus–Infected Patients With Cervical Cancer and Its Precancerous Lesions
Background: Cervical cancer is the second most common cancer in Bangladesh and is primarily caused by persistent high-risk human papillomavirus (HR-HPV) infection. Several risk factors, including immunological, genetic, environmental, and viral factors, may contribute to the development of cervical cancer. Moreover, a disruption in an otherwise delicate balance between immune response and cytokine production may lead to diseased states. Henceforth, this study aimed to determine and compare selected cytokines, including interleukin-6 (IL-6), interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interferon-gamma (INF-γ), interleukin-10 (IL-10), GM-CSF, interleukin-8 (IL-8), and MCP-1 among HR-HPV-infected patients with cervical cancer, precancer individuals, and healthy participants to test the propensity of these cytokines to serve as predictive biomarkers for the detection of cervical cancer during its early stages. Methods: A cross-sectional study was conducted on female patients visiting two referral hospitals in Bangladesh from September to November 2022. Among them, 80 women were enrolled in the study as patients with cervical cancer and precancerous lesions along with HPV DNA–negative healthy individuals. The selected cytokines in the cervical swab were estimated by flow cytometry. Result: Cervical cancer and precancer were primarily detected in patients aged above 40 years (73.3% and 46.7% of the patients in the respective groups). Other significant risk factors, including poor educational, socioeconomic status and nutritional conditions, age of first coitus, multiparity, and tobacco and betel nut consumption, were found significant for the development of cervical cancer and precancer ( P < .05). The levels of IL-6, IL-1β, IL-10, IL-8, and MCP-1 were substantially elevated in patients with cancer than in patients with precancer and healthy individuals ( P < .001). Moreover, the levels of IL-6, IL-1β, IL-10, and IL-8 were also significantly increased in patients with precancer than in healthy individuals ( P < .05). Conclusions: Thus, IL-6, IL-1β, IL-10, IL-8, and MCP-1 can be used as potential biomarkers for diagnostic and prognostic purposes in HPV-induced cervical cancer and precancer.
- Open Access
- 25 August 2023
- Published by Wiley
Robust cellular immune responses to BNT162b2 SARS-CoV-2 mRNA vaccine in T2DM individuals in Bangladesh
Introduction: Diabetes being one of the most common comorbidities of COVID-19, is prioritized for SARS-CoV-2 vaccination. To evaluate the T-cell mediated immune responses in T2DM, this study assessed and compared IFN-\(\gamma\) and IL-2 secreting PBMCs against the SARS-CoV-2 BNT162b2 mRNA vaccine. Methods: 19 known cases of type 2 diabetes and 16 healthy controls were included through purposive sampling and were regularly sampled before 1 st dose, after 1 st and 2 nd dose of vaccination. Ex-vivo ELISpot assays for IFN-\(\gamma\) and IL-2 were done using isolated PBMCs along with HbA1c status and SARS-CoV-2 spike-specific IgG antibody. A p -value < 0.05 was considered significant. Results: All participants were seroconverted after 1 st dose and showed a robust rise of IFN-\(\gamma\) and IL-2 secreting PBMCs counts in T2DM participants irrespective of hypertension, gender and age after 2 doses of vaccination. However, IFN-\(\gamma\) secreting PBMCs counts were significantly lower in type 2 diabetic group than healthy control group after 1 st dose. Conclusion: Although type 2 diabetic participants had a lower response initially, BNT162b2 mRNA vaccine overall induces a robust T-cell mediated immune response- 25 August 2023
- Published by Wiley
Open AccessRobust cellular immune responses to BNT162b2 SARS-CoV-2 mRNA vaccine in T2DM individuals in Bangladesh
Introduction: Diabetes being one of the most common comorbidities of COVID-19, is prioritized for SARS-CoV-2 vaccination. To evaluate the T-cell mediated immune responses in T2DM, this study assessed and compared IFN-\(\gamma\) and IL-2 secreting PBMCs against the SARS-CoV-2 BNT162b2 mRNA vaccine. Methods: 19 known cases of type 2 diabetes and 16 healthy controls were included through purposive sampling and were regularly sampled before 1 st dose, after 1 st and 2 nd dose of vaccination. Ex-vivo ELISpot assays for IFN-\(\gamma\) and IL-2 were done using isolated PBMCs along with HbA1c status and SARS-CoV-2 spike-specific IgG antibody. A p -value < 0.05 was considered significant. Results: All participants were seroconverted after 1 st dose and showed a robust rise of IFN-\(\gamma\) and IL-2 secreting PBMCs counts in T2DM participants irrespective of hypertension, gender and age after 2 doses of vaccination. However, IFN-\(\gamma\) secreting PBMCs counts were significantly lower in type 2 diabetic group than healthy control group after 1 st dose. Conclusion: Although type 2 diabetic participants had a lower response initially, BNT162b2 mRNA vaccine overall induces a robust T-cell mediated immune response - Open Access
- 21 July 2023
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Microbiology
- Vol. 16 (2) , 72-75
A Case Report on Drug-Induced Hepatic Failure in a Young Child Infected with HAV
Hepatitis A virus (HAV) is typical enterovirus that may cause liver damage. This infection may vary in intensity from a few weeks of moderate sickness to many months of severe illness. It may sometimes lead to liver failure and death, especially in individuals with a preexisting health condition or a compromised immune system. Hepatitis A infection is most common in children in developing countries. A very tiny percentage of those who have hepatitis A may die from fulminant hepatitis or extrahepatic manifestations. One of the main causes of liver damage is an adverse drug reaction, which may require withdrawing the offending medication, being hospitalized, or even undergoing liver transplantation. The most frequent cause of acute liver failure is, in fact, drug-induced hepatotoxicity. Acetaminophen is usually used in mild analgesic or antipyretic with in-dose limitations. Use of Acetaminophen during a prodromal period of Hepatitis A may induce acute liver failure from which mild ascites and pleural effusion may develop. There have been isolated cases of these pediatric Hepatitis A symptoms occurring in isolation, but it is highly unusual for them to coexist. In this article, a young boy with Hepatitis A infection is described who had both of these pleural effusions and ascites at the same time. Hepatitis A in children with drug-induced consequences such as liver failure is carefully treated. First-care clinicians must be aware of paracetamol-induced juvenile hepatitis extrahepatic symptoms. This article recommends before fever therapy cause of fever should be excluded. Bangladesh Journal of Medical Microbiology, July 2022;16(2):72-75
- 21 July 2023
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Microbiology
- Vol. 16 (2) , 72-75
Open AccessA Case Report on Drug-Induced Hepatic Failure in a Young Child Infected with HAV
Hepatitis A virus (HAV) is typical enterovirus that may cause liver damage. This infection may vary in intensity from a few weeks of moderate sickness to many months of severe illness. It may sometimes lead to liver failure and death, especially in individuals with a preexisting health condition or a compromised immune system. Hepatitis A infection is most common in children in developing countries. A very tiny percentage of those who have hepatitis A may die from fulminant hepatitis or extrahepatic manifestations. One of the main causes of liver damage is an adverse drug reaction, which may require withdrawing the offending medication, being hospitalized, or even undergoing liver transplantation. The most frequent cause of acute liver failure is, in fact, drug-induced hepatotoxicity. Acetaminophen is usually used in mild analgesic or antipyretic with in-dose limitations. Use of Acetaminophen during a prodromal period of Hepatitis A may induce acute liver failure from which mild ascites and pleural effusion may develop. There have been isolated cases of these pediatric Hepatitis A symptoms occurring in isolation, but it is highly unusual for them to coexist. In this article, a young boy with Hepatitis A infection is described who had both of these pleural effusions and ascites at the same time. Hepatitis A in children with drug-induced consequences such as liver failure is carefully treated. First-care clinicians must be aware of paracetamol-induced juvenile hepatitis extrahepatic symptoms. This article recommends before fever therapy cause of fever should be excluded. Bangladesh Journal of Medical Microbiology, July 2022;16(2):72-75